Thomas H. Carter
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Glioma Diagnosis and Treatment
Papers in
-
- Histone Deacetylase Inhibitors Research 4
- Melanoma and MAPK Pathways 2
- CRISPR and Genetic Engineering 2
-
- Acute Myeloid Leukemia Research 8
- Co-authors
- Morris W. Foster (4 shared papers)Maria R. Baer (4 shared papers)Kati Maharry (4 shared papers)Bayard L. Powell (4 shared papers)Susan P. Whitman (4 shared papers)Guido Marcucci (4 shared papers)Sebastian Schwind (4 shared papers)Heiko Becker (4 shared papers)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (3 papers)Journal of Bacteriology (2 papers)The American Journal of Human Genetics (2 papers)CNS Oncology (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Thomas H. Carter
34 papers receiving 1.6k citations
Thomas H. Carter's Hit Papers
Peers
Comparison fields: 5 of 118
- Hematology 721
- Genetics 354
- Cancer Research 313
- Public Health, Environmental and Occupational Health 330
- Molecular Biology 772
Countries citing papers authored by Thomas H. Carter
This map shows the geographic impact of Thomas H. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas H. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas H. Carter more than expected).
Fields of papers citing papers by Thomas H. Carter
This network shows the impact of papers produced by Thomas H. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas H. Carter. The network helps show where Thomas H. Carter may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas H. Carter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Hit paper breakdown → | 2010 | 548 |
| 2 | 2009 | 241 | |
| 3 | 1991 | 97 | |
| 4 | 2005 | 77 | |
| 5 | 2010 | 77 | |
| 6 | 1998 | 76 | |
| 7 | 1999 | 74 | |
| 8 | 2014 | 67 | |
| 9 | 2016 | 53 | |
| 10 | 2017 | 45 | |
| 11 | 1984 | 44 | |
| 12 | 1997 | 42 | |
| 13 | 1994 | 36 | |
| 14 | 2016 | 29 | |
| 15 | 2015 | 27 | |
| 16 | 2003 | 26 | |
| 17 | 1989 | 26 | |
| 18 | 2011 | 18 | |
| 19 | 1997 | 14 | |
| 20 | 1989 | 11 |
About Thomas H. Carter
Thomas H. Carter is a scholar working on Molecular Biology, Hematology, Public Health, Environmental and Occupational Health, Genetics and Oncology, having authored 34 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), BRCA gene mutations in cancer (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Ethics in Clinical Research (3 papers), Race, Genetics, and Society (3 papers), Melanoma and MAPK Pathways (2 papers), Virus-based gene therapy research (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Hematology (721 citations), Genetics (354 citations), Cancer Research (313 citations), Public Health, Environmental and Occupational Health (330 citations) and Molecular Biology (772 citations). Thomas H. Carter has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Morris W. Foster, Maria R. Baer, Kati Maharry, Bayard L. Powell, Susan P. Whitman, Guido Marcucci, Sebastian Schwind, Heiko Becker, Jonathan E. Kolitz and Richard A. Larson. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Bacteriology, The American Journal of Human Genetics and CNS Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.